213 related articles for article (PubMed ID: 34286513)
1. Soluble syndecan-1 as marker of intestinal inflammation: A preliminary study and evaluation of a new panel of biomarkers for non-invasive prediction of active ulcerative colitis.
Floer M; Clausen M; Meister T; Vollenberg R; Bettenworth D; Tepasse PR
Adv Clin Exp Med; 2021 Jul; 30(7):655-660. PubMed ID: 34286513
[TBL] [Abstract][Full Text] [Related]
2. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
[TBL] [Abstract][Full Text] [Related]
3. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease.
Farias E Silva K; Nanini HF; Cascabulho CM; Rosas SLB; Santana PT; Carneiro AJV; Anaissie E; Nucci M; de Souza HSP
World J Gastroenterol; 2021 Mar; 27(9):866-885. PubMed ID: 33727775
[TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
6. Soluble ST2: a new and promising activity marker in ulcerative colitis.
Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R
World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
[TBL] [Abstract][Full Text] [Related]
8. Activated Syndecan-1 shedding contributes to mice colitis induced by dextran sulfate sodium.
Wang X; Chen Y; Song Y; Zhang S; Xie X; Wang X
Dig Dis Sci; 2011 Apr; 56(4):1047-56. PubMed ID: 20936359
[TBL] [Abstract][Full Text] [Related]
9. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
11. Fecal calprotectin is more accurate than fecal immunochemical test for predicting mucosal healing in quiescent ulcerative colitis: a prospective multicenter study.
Kim ES; Lee HS; Kim SK; Kim EY; Jang BI; Kim KO; Yang CH; Lee YJ;
Scand J Gastroenterol; 2020 Feb; 55(2):163-168. PubMed ID: 31984815
[No Abstract] [Full Text] [Related]
12. Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis.
Zhang Y; Wang Z; Liu J; Zhang S; Fei J; Li J; Zhang T; Wang J; Park PW; Chen Y
J Cell Mol Med; 2017 Jan; 21(1):13-25. PubMed ID: 27558380
[TBL] [Abstract][Full Text] [Related]
13. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
14. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H
J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of faecal calprotectin in ulcerative colitis - single centre experience.
Grgić D; Golubić K; Brinar M; Krznarić Ž
Ann Med; 2022 Dec; 54(1):1570-1577. PubMed ID: 35635011
[TBL] [Abstract][Full Text] [Related]
16. Trefoil Factor 3 is Highly Predictive of Complete Mucosal Healing Independently and in Combination with C-Reactive Protein in Patients with Ulcerative Colitis.
Nakov R; Velikova T; Nakov V; Gerova V; Tankova L
J Gastrointestin Liver Dis; 2019 Jun; 28():169-174. PubMed ID: 31204414
[TBL] [Abstract][Full Text] [Related]
17. Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
Patel A; Panchal H; Dubinsky MC
Inflamm Bowel Dis; 2017 Sep; 23(9):1600-1604. PubMed ID: 28590341
[TBL] [Abstract][Full Text] [Related]
18. Serum neutrophil gelatinase-associated lipocalin (NGAL) correlates with clinical and endoscopic activity in ulcerative colitis but fails to predict activity in Crohn's disease.
Budzynska A; Gawron-Kiszka M; Nowakowska-Dulawa E; Spiewak J; Lesinska M; Kukla M; Waluga M; Hartleb M
J Physiol Pharmacol; 2017 Dec; 68(6):859-865. PubMed ID: 29550798
[TBL] [Abstract][Full Text] [Related]
19. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis.
Motooka K; Morishita K; Ito N; Shinzaki S; Tashiro T; Nojima S; Shimizu K; Date M; Sakata N; Yamada M; Takamatsu S; Kamada Y; Iijima H; Mizushima T; Morii E; Takehara T; Miyoshi E
World J Gastroenterol; 2021 Jan; 27(2):162-175. PubMed ID: 33510557
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis.
Xiang JY; Ouyang Q; Li GD; Xiao NP
World J Gastroenterol; 2008 Jan; 14(1):53-7. PubMed ID: 18176961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]